Chemoinformaics analysis of 4-methoxylonchocarpin
| Molecular Weight | 336.387 | nRot | 4 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 19 |
| Exact Molecular Weight | 336.136 | nRing | 3 |
| Solubility: LogS | -4.665 | nHRing | 1 |
| Solubility: LogP | 5.017 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 51.6139 |
| nHD | 1 | BPOL | 24.4041 |
| QED | 0.66 |
| Synth | 2.532 |
| Natural Product Likeliness | 1.526 |
| NR-PPAR-gamma | 0.977 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.778 |
| MDCK | 0.0000174 |
| BBB | 0.043 |
| PPB | 1.02206 |
| VDSS | 0.533 |
| FU | 0.00705135 |
| CYP1A2-inh | 0.956 |
| CYP1A2-sub | 0.883 |
| CYP2c19-inh | 0.936 |
| CYP2c19-sub | 0.301 |
| CYP2c9-inh | 0.915 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.912 |
| CYP2d6-sub | 0.908 |
| CYP3a4-inh | 0.82 |
| CYP3a4-sub | 0.342 |
| CL | 3.115 |
| T12 | 0.198 |
| hERG | 0.434 |
| Ames | 0.673 |
| ROA | 0.847 |
| SkinSen | 0.901 |
| Carcinogencity | 0.916 |
| EI | 0.179 |
| Respiratory | 0.873 |
| NR-Aromatase | 0.835 |
| Antiviral | Yes |
| Prediction | 0.780075 |